Viewing nowLipino Tablet 20 Milligrams (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
GL Pharma Co., Ltd.

MFDS item code 201801718 · Approved 2018.04.23 · Insurance code 649701740
Improvement of hyperlipidemia; prevention of cardiovascular diseases (such as myocardial infarction and stroke)
This medicine helps reduce the risk of cardiovascular diseases. In particular, it lowers the risk of myocardial infarction and stroke in adults with risk factors for coronary artery disease and in patients with type 2 diabetes. It is also effective in reducing the risk of non-fatal myocardial infarction, stroke, revascularization procedures, hospitalization due to heart failure, and angina. This drug is used to lower cholesterol and triglyceride levels in patients with hyperlipidemia and to increase HDL cholesterol levels. It is especially helpful in treating hypercholesterolemia in pediatric patients with a family history or other risk factors. Overall, it is used to improve cardiovascular health and reduce risk.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (40 mg only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use at the start of treatment and when assessing response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect atorvastatin plasma concentrations or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are generally similar to those in the usual adult patient population.
Pediatric patients (10 ~ 17 years) with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses higher than 20 mg of this medicine in pediatric patients).
This medication may pose a risk of muscle problems; if symptoms such as muscle pain or weakness occur, discontinue use immediately and consult a physician. Especially, in suspected cases of severe myopathy or rhabdomyolysis, treatment should be stopped, and care should be taken in patients with poor kidney function or a history of liver disease. This medication can affect liver function; therefore, regular liver function tests should be conducted, and any abnormal symptoms should be reported immediately. Women who are pregnant or may become pregnant, and nursing mothers should not take this medication, and women of childbearing age should use appropriate contraception while on this medication. It should not be used in children under 10 years of age, and caution is also needed when administering to elderly patients or those with kidney impairments. This medication can interact with certain drugs, increasing the risk of side effects; therefore, inform your doctor or pharmacist if you are taking any other medications. If allergic reactions, skin rashes, or hives occur, discontinue use and consult medical personnel immediately. There is no specific antidote for overdose, treatment should be symptom-based, and keep out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, to maintain its effect, it is important to store it at room temperature, between 1 and 30 degrees Celsius.
White oval film-coated tablet
30 tablets/bottle, 120 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
GL Pharma Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.